Literature DB >> 2395081

Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study.

C P Archibald1, M T Schechter, K J Craib, T N Le, B Douglas, B Willoughby, M O'Shaughnessy.   

Abstract

In our ongoing cohort study of homosexual men, the ratio of new Kaposi's sarcoma (KS) cases to new opportunistic infections (OI) during the periods 1982-1985, 1986-1987, and 1988-1989 fell from 0.75 (9 KS: 12 OI) to 0.57 (12 KS:21 OI) to 0.27 (4 KS:15 OI), respectively. To examine factors associated with the development of KS as compared to OI, we compared antecedent risk factors in 25 KS cases and 48 OI "controls." In univariate analyses, several classical HIV risk factors including numbers of sexual partners and receptive anal intercourse were higher in the KS than the OI group. The strongest associations were found with an elevated number of sex partners in high-risk areas (San Francisco, Los Angeles, and New York) in the 5 years prior to enrollment and with elevated use of nitrite inhalants. Logistic regression revealed the latter two variables and an elevated number of partners contacted in washrooms/parks to be significant, independent risk factors for KS relative to OI. Any or all of these variables could be related with early HIV infection. However, the association with early sexual contact in high-risk areas raises the more intriguing possibility that this variable is an indicator of an increased exposure either to a particular strain of HIV that is more pathogenic for KS, or, more likely, to a sexually transmitted KS cofactor that may have been more highly concentrated in these areas at this early point in the epidemic. The present study supports an independent association with use of nitrite inhalants, which could be hypothesized either to have an independent biologic effect on KS or to enhance the efficiency of transmission of the cofactor virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395081

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  6 in total

1.  Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.

Authors:  Eric W Nawar; Stephen R Cole; Homayoon Farzadegan; Mallory D Witt; Frank J Jenkins; Joseph B Margolick; John P Phair; Lisa P Jacobson
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

Review 2.  Effects of inhalant nitrites on VEGF expression: a feasible link to Kaposi's sarcoma?

Authors:  Ho-Leung Fung; Doanh C Tran
Journal:  J Neuroimmune Pharmacol       Date:  2006-09       Impact factor: 4.147

Review 3.  Molecular approaches to the identification of unculturable infectious agents.

Authors:  S J Gao; P S Moore
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

4.  An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis and Treatment.

Authors:  Paul Curtiss; Lauren C Strazzulla; Alvin E Friedman-Kien
Journal:  Dermatol Ther (Heidelb)       Date:  2016-11-01

5.  Long-term nitrite inhalant exposure and cancer risk in MSM.

Authors:  Anupriya Dutta; Hajime Uno; Alex Holman; David R Lorenz; Steven M Wolinsky; Dana Gabuzda
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

Review 6.  Nitrite inhalants: history, epidemiology, and possible links to AIDS.

Authors:  H W Haverkos; A N Kopstein; H Wilson; P Drotman
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.